Nicaragua vs Panama: Cause of death, by non-communicable diseases, ages 15-59
Nicaragua
46.8%
in 2021
Panama
47.5%
in 2021
Nicaragua rank
118th
Panama rank
116th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Nicaragua
- Panama
How they compare
Panama currently reports 47.5% against 46.8% in Nicaragua, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Nicaragua ahead.
Nicaragua ranks 118th and Panama ranks 116th of 185 countries.
Nicaragua has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.3% | 46.8% | 7.5% | Nicaragua |
| 2010s | 64.3% | 53.1% | 11.3% | Nicaragua |
| 2020s | 48.6% | 45.7% | 2.9% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Nicaragua or Panama?
- Panama, at 47.5% against 46.8% in Nicaragua as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Nicaragua and Panama?
- 0.7%, with Panama ahead.
- How many years of comparable data are there for Nicaragua and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do Nicaragua and Panama rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Nicaragua ranks 118th and Panama ranks 116th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.